CHELSEA HEILMAN: Open Payments
NPI 1134525827 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 11 payments from 7 companies in 2025. Trend: 2023 $190 · 2024 $151 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 1 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Exact Sciences Corporation | 2 | $39 |
| PFIZER INC. | 2 | $38 |
| Novo Nordisk Inc | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $14 |
Products named: FUROSCIX, CAPLYTA, NURTEC ODT, Wegovy, Cologuard Collection Kit, The Cologuard Plus Collection Kit, Kerendia, Korlym.
Industry payments across PA — which companies pay providers there.
